Victory Capital Management
RYTM icon

Victory Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Victory Capital Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.68M Buy
28,131
+20,452
+266% +$2.18M ﹤0.01% 1576
2026
Q2 		$853K Sell
7,679
-12,825
-63% -$1.16M ﹤0.01% 1950
2026
Q1 		$1.78M Sell
20,504
-24,877
-55% -$2.42M ﹤0.01% 1640
2025
Q4 		$4.86M Buy
45,381
+2,498
+6% +$265K ﹤0.01% 1325
2025
Q3 		$4.33M Buy
42,883
+26,642
+164% +$2.47M ﹤0.01% 1383
2025
Q2 		$1.03M Sell
16,241
-1,085
-6% -$66.4K ﹤0.01% 1841
2025
Q1 		$918K Buy
17,326
+174
+1% +$9.7K ﹤0.01% 1840
2024
Q4 		$960K Sell
17,152
-1,034
-6% -$57.1K ﹤0.01% 1829
2024
Q3 		$953K Buy
18,186
+11,137
+158% +$534K ﹤0.01% 1795
2024
Q2 		$289K Sell
7,049
-8,036
-53% -$321K ﹤0.01% 2109
2024
Q1 		$654K Sell
15,085
-167,212
-92% -$7.32M ﹤0.01% 1903
2023
Q4 		$8.38M Buy
182,297
+162,247
+809% +$5.12M 0.01% 1118
2023
Q3 		$460K Buy
+20,050
New +$449K ﹤0.01% 2012
2020
Q2 		– Sell
-4,274
Closed -$65K – 3142
2020
Q1 		$65K Sell
4,274
-1,793
-30% -$32.1K ﹤0.01% 2446
2019
Q4 		$139K Buy
6,067
+3,277
+117% +$72.8K ﹤0.01% 2422
2019
Q3 		$60K Buy
+2,790
New +$59.9K ﹤0.01% 2606

Other funds holding RYTM

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Victory Capital Management's RYTM Position: Q3 2026 in Review

Victory Capital Management increased its Rhythm Pharmaceuticals (RYTM) stake by 266% in Q3 2026, buying an estimated $2.18M and bringing the position to 28,131 shares worth $2.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1576.

Victory Capital Management first reported a position in RYTM in Q3 2019 and has held it in 16 quarters since. The position peaked at $8.38M in Q4 2023. 239 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

  • Victory Capital Management held 28,131 shares of Rhythm Pharmaceuticals worth $2.68M as of Q3 2026.
  • Victory Capital Management bought 20,452 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $2.18M.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Victory Capital Management's portfolio in Q3 2026, its #1576 holding.
  • Victory Capital Management first reported a position in Rhythm Pharmaceuticals in Q3 2019 and has held it in 16 quarters since.
  • Victory Capital Management's Rhythm Pharmaceuticals position peaked at $8.38M in Q4 2023.
  • 239 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on Victory Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.